The U.S. Food and Drug Administration (FDA) has rejected a request to authorize a drug as a COVID-19 treatment for hospitalized patients.
Florida-based Veru said March 2 that the FDA informed the company it would not grant emergency use authorization (EUA) for sabizabulin, the drug.
